How Inflation Reduction Act will lower prescription drug prices

More from this show

The new Inflation Reduction Act, just signed into law by President Biden last week, will put a cap on out-of-pocket prescription drug prices for Medicare recipients.

Dana Marie Kennedy, the State Director of AARP Arizona spoke to us about what it will mean.

Launching a long-sought goal, the Act will allow the Medicare program to negotiate some prescription drug prices with pharmaceutical companies, saving the federal government some $288 billion over the 10-year budget window.

The result is expected to lower costs for older adults on medications, including a $2,000 out-of-pocket cap for older adults buying prescriptions from pharmacies.

The revenue raised would also be used to provide free vaccinations for seniors, who now are among the few not guaranteed free access, according to a summary document.

Seniors would also have insulin prices capped at $35 a month.

Dana Marie Kennedy/State Director, AARP Arizona

Pavlo: Live in Santorini
airs Dec. 3

Don’t miss ‘Pavlo: Live in Santorini’

aired Nov. 28

Stewart Udall: The Politics of Beauty

Proposal for Phoenix Latino Cultural Center

Don’t miss ‘Horizonte’ Saturdays at 6 p.m.

Our Voices: August Wood on preserving cultural artisan traditions

August Wood on preserving cultural artisan traditions

Subscribe to Arizona PBS Newsletters

STAY in touch
with azpbs.org!

Subscribe to Arizona PBS Newsletters: